Related Experiment Video
Updated: Jun 22, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS
Damien Vitour1, Stéphanie Dabo1, Malek Ahmadi Pour1
1Unit of Hepacivirus and Innate Immunity, 75015, Paris, France.
Abstract:
The mitochondria-bound adapter MAVS participates in IFN induction by recruitment of downstream partners such as members of the TRAF family, leading to activation of NF-kappaB, and the IRF3 pathways. A yeast two-hybrid search for MAVS-interacting proteins yielded the Polo-box domain (PBD) of the mitotic Polo-like kinase PLK1. We showed that PBD associates with two different domains of MAVS in both dependent and independent phosphorylation events. The phosphodependent association requires the phosphopeptide binding ability of PBD. It takes place downstream of the proline-rich domain of MAVS, within an STP motif, characteristic of the binding of PLK1 to its targets, where the central Thr234 residue is phosphorylated. Its phosphoindependent association takes place at the C terminus of MAVS. PLK1 strongly inhibits the ability of MAVS to activate the IRF3 and NF-kappaB pathways and to induce IFN. Reciprocally, depletion of PLK1 can increase IFN induction in response to RIG-I/SeV or RIG-I/poly(I)-poly(C) treatments. This inhibition is dependent on the phosphoindependent association of PBD at the C terminus of MAVS where it disrupts the association of MAVS with its downstream partner TRAF3. IFN induction was strongly inhibited in cells arrested in G2/M by nocodazole, which provokes increased expression of endogenous PLK1. Interestingly, depletion of PLK1 from these nocodazole-treated cells could restore, at least partially, IFN induction. Altogether, these data demonstrate a new function for PLK1 as a regulator of IFN induction and provide the basis for the development of inhibitors preventing the PLK1/MAVS association to sustain innate immunity.
Insights
Polo-like kinase 1 (PLK1) inhibits interferon (IFN) production by binding to the MAVS protein, a key adapter in innate immunity signaling pathways. This discovery reveals PLK1 as a novel regulator of IFN induction.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Mitochondria-bound adapter MAVS is crucial for interferon (IFN) induction via NF-kappaB and IRF3 pathways.
- MAVS recruits downstream partners like TRAF family members to initiate signaling cascades.
Purpose of the Study:
- To identify MAVS-interacting proteins and elucidate their role in IFN induction.
- To investigate the function of Polo-like kinase 1 (PLK1) in regulating MAVS-mediated innate immune responses.
Main Methods:
- Yeast two-hybrid screening to identify MAVS-binding proteins.
- Co-immunoprecipitation and Western blotting to analyze protein interactions and phosphorylation.
- Interferon induction assays in response to various stimuli.
- RNA interference (RNAi) to deplete PLK1 levels.
- Cell cycle arrest using nocodazole.
Main Results:
- The Polo-box domain (PBD) of PLK1 was identified as a MAVS-interacting protein.
- PLK1 binds to MAVS through both phosphodependent and phosphoindependent mechanisms.
- PLK1 inhibits MAVS-mediated activation of IRF3 and NF-kappaB pathways, thereby suppressing IFN induction.
- Depletion of PLK1 enhances IFN induction, particularly under conditions of cell cycle arrest.
- PLK1's phosphoindependent interaction with MAVS disrupts TRAF3 binding, inhibiting downstream signaling.
Conclusions:
- PLK1 acts as a novel negative regulator of IFN induction by directly inhibiting MAVS function.
- The interaction between PLK1 and MAVS offers a potential target for therapeutic interventions to boost innate immunity.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

